Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland
· Delayed Price · Currency is CHF 53.50
+0.30 (0.56%)
Apr 28, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 657.60 million as of April 28, 2026. Its market cap has increased by 32.55% in one year.
Market Cap
657.60M
Enterprise Value
587.02M
Revenue
232.38M
Ranking
n/a
PE Ratio
17.03
Stock Price
53.50
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 657.60M, an increase of 23.31%. That is a compound annual growth rate of 0.95%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 946.67M |
| Newron Pharmaceuticals | 318.74M |
| Santhera Pharmaceuticals Holding AG | 255.69M |
| BioVersys AG | 172.52M |
| Molecular Partners AG | 125.33M |
| Xlife Sciences AG | 122.85M |
| MindMaze Therapeutics Holding | 45.93M |
| EvoNext Holdings | 6.88M |